1. Market Research
  2. > Pathology
6 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Global CML Market Report - 2022

  • $ 3849
  • June 2018
  • 82 pages

Imatinib mesylate is licensed as a firstline treatment for adults with chronic-phase Ph+ CML, and for the management of GIST, and as salvage therapy for Ph+ acute lymphoblastic lymphoma.

  • Lymphoma
  • Therapy
  • Incyte Corporation
  • Merck & Co., Inc.
  • Novartis AG

Global Gene Therapy Market Report - 2026

  • $ 3849
  • July 2018
  • 105 pages

Lymphoma, B-Cell Lymphoma Cd##+ Diffuse Large B-Cell Lymphoma Undisclosed (Expected Oncology) Prostate Cancer, Lung Cancer Phase ## CTL## CAR-T Phase ##I BiTE platform CAR-T Phase ## LADD iMultiple Myelomauno-oncology platform Up to ## gene therapies including S##A## Phase ##

  • Gene Therapy
  • Lymphoma
  • Therapy
  • Boehringer Ingelheim GmbH
  • Celgene Corporation

Global Molecular Diagnostics Market Report - 2026

  • $ 3499
  • September 2018
  • 83 pages

Hematology Disorders Molecular diagnostics tests are used in hematological disorders such as myeloid neoplasm, Lymphoma, Leukemia, Lymphoid Neoplasms, B-Cell, T-Cell, and Minimal Residual Disease.

  • Biotech Diagnostics
  • Lymphoma
  • Molecular Diagnostics
  • bioMerieux S.A.
  • QIAGEN N.V.

Gaucher Disease Market Report - 2026

  • $ 3499
  • August 2018
  • 145 pages

Figure ##: Inheritance Pattern of Gaucher Disease Inheritance Pattern Gaucher Disease increases the risk of developing various disorders such as Parkinson' s disease, myeloma, leukemia, lymphoma, and others.

  • Lymphoma
  • Pathology
  • Therapy
  • Enanta Pharmaceuticals, Inc.
  • Genzyme Corporation

Global CAR-T Pipeline Analysis Report in Oncology 2018

  • $ 3499
  • December 2018
  • 108 pages

Yescarta was approved in October 2017, for adult patients with relapsed or refractory large B- cell lymphoma after two or more lines of systemic therapy, including: diffuse large B-cell lymphoma (DLBCL) not otherwise specified; primary mediastinal large B-cell lymphoma (PM

  • Immunotherapy
  • Lymphoma
  • Medical Biotechnology
  • Pharmaceutical
  • Therapy

Global Lupus Nephritis Market Report - 2026

  • $ 3849
  • July 2018
  • 99 pages

People who have LN are at a high risk for cancer, primarily B-cell lymphoma, a type of cancer that begins in the cells of the immune system.

  • Genitourinary System Disease
  • Lymphoma
  • Medical Biotechnology
  • Musculoskeletal Disorder
  • Therapy


View report >

Lymphoma Statistics in the UK

  • January 2018
  • 6 pages

(observed and ##. ##% five years from a lymphoma diagnosis in 2009-2013.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Demographic

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on